GMAB · NASDAQ · Biotechnology

Genmab (ADR) (GMAB)

Develops antibody medicines through partner royalties, co-commercialization, and a wholly owned oncology portfolio.

$35.22
After-hours close+0.01 (+0.03%)
At close$35.21(+1.50%)